Home›People›Bruce Batten
Bruce Batten

Bruce Batten

Founder and chief scientific officer, GRIP Molecular Technologies Inc.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Oct 29, 2026·Suggest an edit

About Bruce Batten

Bruce Batten is the founder and chief scientific officer of GRIP Molecular Technologies Inc. in Saint Paul, Minnesota. GRIP builds a diagnostic platform on a CRISPR protease that detects pathogen RNA.

He has spent more than 30 years in general management, at BioRad, Thermo Instruments, CyberOptics, and Advantek. He has served at the C-level in four technology startups. He founded two startups before launching GRIP. He holds a Ph.D. in anatomy and cell biology from the Medical College of Virginia. He did a postdoc at Harvard Medical School and held faculty posts at the medical schools of Harvard, Tufts, and Ohio State. He later ran the MBA program at Augsburg University.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Bruce Batten in the role, so the role may have started earlier or lasted longer.

GRIP Molecular Technologies Inc. Current
Founder | CSO
2019 – Present · Saint Paul, MN
A CRISPR protease test platform that detects pathogen RNA in minutes and works with several readout formats.
BioRad
Thermo Instruments
CyberOptics
Advantek
Augsburg University

Key Colleagues at Startups

The people Bruce Batten works with at each company, as listed on that company's latest Form D.

GRIP Molecular Technologies Inc. · Form D/A, Oct 29, 2026

Sources

  1. SECGRIP Molecular Technologies Inc. Form D/A, filed Oct 29, 2026
  2. companyGRIP Molecular Technologies home page